mesalamine has been researched along with Cardiac Hypertrophy in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukherjee, N | 1 |
| Pandya, N | 1 |
| Bhaduri, B | 1 |
| Bala, K | 1 |
1 other study available for mesalamine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Chest pain in a 12-year-old girl with ulcerative colitis after therapy with mesalazine.
Topics: Anti-Inflammatory Agents; Cardiomegaly; Chest Pain; Child; Colitis, Ulcerative; Echocardiography; El | 2013 |